Harnessing Evolution to Cure Prion Diseases
Heprion is a deep-science biotechnology start-up that leverages physiological processes refined through evolution to tackle prion diseases.
Research Advancements
Our research focuses on deriving innovative treatment ideas from an understanding of disease mechanisms.
Develop the first curative treatment for prion diseases.
Join us in advancing prion therapeutics and partner with us in our quest for a future without prion diseases.
Our Mission
Partner with us
We take a science-first approach to engineering one-time, curative therapies designed for precision and minimal off-target effects. Leveraging deep expertise in prion biology, we create designer molecules that directly address the root cause of prion diseases.
No Approved Treatments
Prion diseases are rapidly progressing and universally fatal illnesses. These diseases kill approximately 1 in 5,000 humans.
Despite their severity, no treatments are approved for clinical use. Patients typically experience rapid decline, with survival measured in months following diagnosis.
This stark reality underscores the urgent need for effective therapies.
Innovative Strategy
Therapeutic Research and Discovery
We specialize in advancing treatments for neurodegenerative diseases, focusing on prion disease research and development.
Cutting-Edge Research
Our team conducts pioneering research to understands prion biology, enabling us to design molecules that can combat prion diseases effectively.
Collaborative Partnerships
We collaborate with leading institutions and thought leaders with access to relevant human infectious prion pathogens to conduct efficacy studies.
Interventions in the central nervous system require state-of-the-art delivery solutions. Our in-house expertise in viral technology enables our therapeutic pipeline.
Engineering therapeutic delivery
Research
Harnessing evolution to create designer molecules that could halt neurodegeneration.
Contact
Support
heprion@gmail.com
© 2025. All rights reserved.